# Sources — Hippocrates

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

Accessed November 6, 2026. The canonical source metadata and claim links are in `case.json`.

## Historical evidence

1. Jones WHS. *Hippocrates*, with an English translation, vol. I, General Introduction (Loeb Classical Library, 1923), Internet Archive (University of Toronto copy). Sections on the Corpus, the life and the Asclepiadae read. “We possess three ancient biographies of Hippocrates: one by Suidas, one by Tzetzes, and one by Soranus, a late writer of uncertain date”; from these, that he “was born in Cos in 460 B.C.,” of the Asclepiadae, son of Heraclides, and that “his life was a long one but of uncertain length, the traditions making him live 85, 90, 104 or 109 years”; “In these accounts there is a certain amount of fable,” and the staying of the Athenian plague “is directly contrary to the testimony of Thucydides”; Plato's two references (Protagoras and Phaedrus); “From Aristotle we learn that Hippocrates was already known as ‘the Great Hippocrates’”; “a name without writings, as Wilamowitz says”; Aristotle assigns a treatise “not [to] Hippocrates but Polybus”; the collection is “the remains of a library” with works “of various dates and of different schools,” a great part of it “neither by Hippocrates himself nor by his school”; a footnote that Aulus Gellius made him older than Socrates. https://archive.org/details/hippocrates01hippuoft
2. Plato. *Protagoras*, translated by Benjamin Jowett (Project Gutenberg eBook #1591). “If, for example, you had thought of going to Hippocrates of Cos, the Asclepiad, and were about to give him your money …” https://www.gutenberg.org/ebooks/1591
3. Suda On Line, iota 564, “Hippocrates,” translated by Carl Widstrand (2000), with editors' notes (Stoa Consortium, University of Kentucky). Son of Heraclides; taught first by his father; “He died in Thessaly and was buried at Larissa”; died “at about 104 years old”; the notes say that a family tradition of teachers “comes from Soranus via Tzetzes and is probably spurious (Jouanna, p.18).” https://www.cs.uky.edu/~raphael/sol/sol-entries/iota/564
4. Yapijakis C. “Hippocrates of Kos, the father of clinical medicine, and Asclepiades of Bithynia, the father of molecular medicine.” *In Vivo* 2009;23(4):507-514 (PMID 19567383). Abstract read: “Hippocrates of Kos (460-377 Before Common Era, BCE) is universally recognized as the father of modern medicine, which is based on observation of clinical signs and rational conclusions.” https://pubmed.ncbi.nlm.nih.gov/19567383/
5. Kostakopoulos NA, Bellos TC, Katsimperis S, Tzelves L. “Hippocrates of Kos (460-377 BC): The Founder and Pioneer of Clinical Medicine.” *Cureus* 2024;16(10):e70602 (PMID 39483540; PMC11526839). Full text read: born “on the Aegean island of Kos during the fifth century”; “the founding father of clinical medicine.” https://pubmed.ncbi.nlm.nih.gov/39483540/
6. HISTMED Master Roster v3. Internal project source; not treated as independent corroboration.

## Clinical guidance

1. Institute for Healthcare Improvement and The John A. Hartford Foundation. Age-Friendly Health Systems: “a set of four evidence-based elements of high-quality care, known as the ‘4Ms,’” What Matters, Medication, Mentation and Mobility. https://www.ihi.org/networks/initiatives/age-friendly-health-systems
2. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. *J Am Geriatr Soc* 2023;71(7):2052-2081 (PMID 37139824): avoid chronic oral NSAIDs and strongly anticholinergic first-generation antihistamines such as diphenhydramine. https://pubmed.ncbi.nlm.nih.gov/37139824/
3. Johnson TM 2nd, et al. Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup. *J Am Geriatr Soc* 2025;73(7):2019-2028 (PMID 39887356). https://pubmed.ncbi.nlm.nih.gov/39887356/
4. Montero-Odasso M, et al. World guidelines for falls prevention and management for older adults: a global initiative. *Age Ageing* 2022;51(9):afac205 (PMID 36178003): gait speed, the Timed Up and Go, strength and balance exercise, medication review and home hazards. https://pubmed.ncbi.nlm.nih.gov/36178003/
5. U.S. Preventive Services Task Force. Falls Prevention in Community-Dwelling Older Adults: Interventions (2024): exercise for adults 65 and older at increased risk of falls. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/falls-prevention-community-dwelling-older-adults-interventions
6. Dent E, et al. Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management. *J Nutr Health Aging* 2019;23(9):771-787 (PMID 31641726): screening with validated tools such as the FRAIL scale and the Clinical Frailty Scale, and progressive resistance exercise. https://pubmed.ncbi.nlm.nih.gov/31641726/
7. Kolasinski SL, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee. *Arthritis Care Res* 2020;72(2):149-162 (PMID 31908149): exercise, tai chi and topical NSAIDs strongly recommended for knee osteoarthritis. https://pubmed.ncbi.nlm.nih.gov/31908149/
8. LeBoff MS, et al. The clinician's guide to prevention and treatment of osteoporosis (Bone Health and Osteoporosis Foundation). *Osteoporos Int* 2022;33(10):2049-2102 (PMID 35478046): DXA for men 70 and older and treatment at a FRAX 10-year risk of 20 percent (major) or 3 percent (hip). https://pubmed.ncbi.nlm.nih.gov/35478046/
9. Watts NB, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. *J Clin Endocrinol Metab* 2012;97(6):1802-1822 (PMID 22675062). https://pubmed.ncbi.nlm.nih.gov/22675062/
10. U.S. Preventive Services Task Force. Osteoporosis to Prevent Fractures: Screening (2025): evidence insufficient for screening men. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening
11. CMID: Clinical Monitoring Intelligence Database (Aether Forge, 2026), rheumatoid arthritis and osteoarthritis, and osteoporosis monographs: for osteoarthritis, pain and function (KOOS) at each visit, a joint examination, exercise adherence and gait and balance, ALT only with chronic acetaminophen near 3 g a day, and no routine X-ray; for bone health, 25-hydroxyvitamin D at baseline and after repletion, DXA every two years untreated, yearly height and a falls screen. https://patrickrutledge.github.io/topthirty/
12. Centers for Disease Control and Prevention. Adult Immunization Schedule by Age: PCV20 for adults 50 and older, a single RSV vaccine dose at 75 and older, two doses of recombinant zoster vaccine, and high-dose influenza vaccine at 65 and older. https://www.cdc.gov/vaccines/hcp/imz-schedules/adult-age.html
13. U.S. Preventive Services Task Force: the A and B recommendations, with their age limits. https://www.uspreventiveservicestaskforce.org/uspstf/recommendation-topics/uspstf-a-and-b-recommendations
14. Medicare Preventive Services reference (Aether Forge, 2026). https://patrickrutledge.github.io/preventative_services/

## Editorial resolutions

- **Sources and how little is knowable.** Nothing written about him survives from his own lifetime except a few references: Plato names him twice and Aristotle once. The three ancient lives (Soranus, the Suda, Tzetzes) were written many centuries later and mix fact with legend; the Loeb editor and the Suda's modern editors say so. Claims are graded D only where an ancient witness plainly reports a fact that modern scholars accept (a physician and teacher of Cos, an Asclepiad, born about 460 BC; died in Thessaly and buried at Larissa); the length of his life is graded R, disputed. Nothing about his own health is documented (CLM-0007), and the record does not invent any: the chart is thin on purpose. The Stanford Encyclopedia of Philosophy had no entry at the address tried (it returned not found), the National Library of Medicine page tried is no longer maintained and has no content, and Britannica could not be read; the Loeb introduction, the Suda On Line and two peer-reviewed reviews are used instead.
- **Name.** The display name is “Hippocrates.” He is known by a single name, so `identity.name_parts` has an empty given array and the name as the family name, as in the other single-name records. “Hippocrates of Kos” is the alias and appears in no other record. The sources spell the island both Cos and Kos; the record uses each source's spelling.
- **Dates (rule 28).** Historical dates use signed astronomical years: birth -0459 (about 460 BC, approximate), with the Loeb editor's note that Aulus Gellius would put it before 470 BC recorded as unresolved; death -0369 (about 370 BC, approximate), following the roster and the ninety-year tradition, with 377 BC (two medical reviews) and about 356 BC (the Suda's 104 years) recorded as unresolved alternatives. The brief's range of 83 to over 100 years is corrected to the traditions the Loeb editor gives (85, 90, 104 or 109). Calendars are “unknown” because no ancient date for him is a calendar date. The record has no true-date variant (docs/date-shifting.md).
- **Index age and dates.** The index visit on March 2, 2026 maps to March 2, 371 BC, at 89 (synthetic date of birth January 10, 1937; shift 2,396 years), one year before the approximate death year so that every visit (March to September 371 BC) falls within his life under the ninety-year tradition. If the 85-year tradition were right, he would have died before these dates; no tradition is certain, and the record says so. The setting at Larissa, where the Suda says he died and was buried, is assumed; where he lived in his last years is not recorded.
- **The Hippocratic Corpus (CLM-0005, D).** The Corpus was written by many authors, of different schools, over a long period, and a great part of it is neither by him nor by his school. No sentence from the Corpus is attributed to him in the record, and nothing in it is used as a fact about his health.
- **Thin chart (rule 26).** Because nothing about his health is documented, the modern episode is built around normal aging: an independent 89-year-old physician whose wellness screening at his previous practice noted slower walking, leading to a comprehensive geriatric assessment, care centered on the Age-Friendly 4Ms, and one mild common condition (knee osteoarthritis) so that the chronic-care visits have a purpose. Every finding is synthetic and is not a claim about his real body or mind.
- **Presenting problem.** The slower gait, knee pain and near-fall found at intake are recorded as their own problem (R26.81), resolved at the consultation when knee osteoarthritis with reduced strength and balance, with diphenhydramine at night adding to the risk, was diagnosed. The brief's “annual wellness visit leads to the episode” is read as a wellness screening at his previous practice a year before, which prompted the intake assessment; this clinic's subsequent annual wellness visit falls a year after it.
- **Frailty scales.** The Clinical Frailty Scale, the FRAIL scale, the Timed Up and Go, gait speed, the 30-second chair stand, the four-stage balance test, the MNA-SF and the whispered voice test are recorded as narrative because they have no LOINC code used in the record; grip strength, MoCA, Mini-Cog, GDS-15, PHQ-2, KOOS JR, the pain score, the DXA T-scores and FRAX are coded.
- **Clinical judgment calls.** (1) Knee osteoarthritis diagnosed on the ACR clinical criteria without an X-ray, as ACR/AF 2019 and the CMID allow. (2) Over-the-counter naproxen and diphenhydramine stopped (Beers 2023); acetaminophen limited to 3,000 mg a day at 89; topical diclofenac, whose blood levels are low, accepted. (3) A sleep routine rather than any sleep medicine. (4) Vitamin B12 and TSH checked once for slowing gait; both normal. (5) DXA in a man of 89 at risk of falls (BHOF and the Endocrine Society), although USPSTF finds the evidence insufficient for screening men. (6) No osteoporosis medicine at a FRAX risk of 11 percent (major) and 2.6 percent (hip), below the BHOF thresholds; repeat DXA in two years. (7) Twelve weeks of a strength and balance program based on Otago, then tai chi, rather than a walking aid, at his choice. (8) PCV20 after PPSV23 at 65, a single RSV dose, two recombinant zoster doses and high-dose influenza vaccine. (9) Cancer, diabetes, lipid, hepatitis C and HIV screening not indicated at 89. (10) Pre-frailty (FRAIL 1) reassessed after the program (FRAIL 0).
- **Relatives and other real people.** The ancient lives name his father; no relative appears in the modern episode. The health care agent is “a long-time friend,” unnamed. No real person has a statement, decision or health fact in the modern episode. No family medical history is recorded.
- **Synthetic clinical picture.** Everything in the modern episode is synthetic: every result, the DXA, the frailty and mobility measures, the examination findings, the scores, the medicines, the vaccines and the outcomes. Height (168 cm) and weights are synthetic.
- **Annual wellness visit.** A subsequent annual wellness visit at 89 (HCPCS G0439 with CPT 99497 in plain text): the health risk assessment, Mini-Cog 5, PHQ-2 0, hearing and vision, falls and home safety, the prevention plan with screening not indicated at his age, RSV and the first recombinant zoster dose, and advance care planning centered on what matters most to him (full treatment for a reversible illness; comfort-focused care at home, without resuscitation, ventilation or tube feeding, if he could no longer recognize or speak with people).
- **Sick visit.** A common cold, chosen because it is common at his age, tests the deprescribing plan (a nighttime cold remedy with diphenhydramine and a decongestant made him unsteady at night; saline, honey and acetaminophen instead; no antibiotics) and the falls plan, and points at no documented illness. It is not a historical claim.
- **Focused visits.** The four chronic-care follow-ups (two weeks with the consultation, eight weeks, four months and seven months) are documented as focused visits on the CMID osteoarthritis and osteoporosis monographs with ACR/AF 2019, BHOF 2022 and the Endocrine Society 2012, the AGS Beers Criteria 2023, STEADI (AGS 2025) and the World Falls Guidelines, the ICFSR frailty guideline, and the Age-Friendly 4Ms. One deviation is recorded instead of an invented result: the KOOS JR was not given at eight weeks because the form was left out of the visit packet; no harm was likely (the pain score and examination recorded that day both showed improvement, and the score at four months was 74, from 62); KOOS JR was added to the visit template. Synthetic findings introduced: low bone mass on DXA with vitamin D repleted from 24 to 33 ng/mL, gait speed 0.78 to 0.96 m/s, Timed Up and Go 13.8 to 10.9 seconds, KOOS JR 62 to 76, and no falls.
- **Consultation.** The geriatric medicine referral and the consultation by Aristide Lindqvist-Bamba, MD (a fictional consultant), on the day of the two-week visit, are **S**. The consultant answers the five referral questions in line with what the record shows afterwards: knee osteoarthritis with weakness and diphenhydramine as the causes, no X-ray; naproxen and diphenhydramine kept stopped, with topical diclofenac, acetaminophen and a sleep routine; pre-frailty treated with twelve weeks of strength and balance training and then tai chi; a home safety check, a second stair rail and proper shoes; and DXA with FRAX, with medicine only above the thresholds (not reached).
